BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang TY, Portincasa P, Liu M, Tso P, Wang DQ. Mouse models of gallstone disease. Curr Opin Gastroenterol 2018;34:59-70. [PMID: 29266008 DOI: 10.1097/MOG.0000000000000417] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Ueda H, Honda A, Miyazaki T, Morishita Y, Hirayama T, Iwamoto J, Nakamoto N, Ikegami T. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition. PLoS One 2022;17:e0271308. [PMID: 35819971 DOI: 10.1371/journal.pone.0271308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang HH, Portincasa P, Liu M, Wang DQ. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis. Genes (Basel) 2022;13:1047. [PMID: 35741809 DOI: 10.3390/genes13061047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Park S, Zhang T, Yue Y, Wu X. Effects of Bile Acid Modulation by Dietary Fat, Cholecystectomy, and Bile Acid Sequestrant on Energy, Glucose, and Lipid Metabolism and Gut Microbiota in Mice. Int J Mol Sci 2022;23:5935. [PMID: 35682613 DOI: 10.3390/ijms23115935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Zhuang Q, Cheng J, Xia J, Ning M, Wu S, Shen S, Shi Y, Huang D, Dong Z, Wan X. Gypenosides Prevent and Dissolve Cholesterol Gallstones by Modulating the Homeostasis of Cholesterol and Bile Acids. Front Med (Lausanne) 2022;9:818144. [PMID: 35445045 DOI: 10.3389/fmed.2022.818144] [Reference Citation Analysis]
5 Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, Ding Y. Factors Influencing Gallstone Formation: A Review of the Literature. Biomolecules 2022;12:550. [DOI: 10.3390/biom12040550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Lei YM, Yan R, Gao YD, Yang HJ, Bi HY, Duan YQ. Cholesterol crystals activate NLRP3 inflammasomes and promote gallstone formation by increasing mucin secretion. Biotech Histochem 2022;:1-8. [PMID: 35227133 DOI: 10.1080/10520295.2022.2036813] [Reference Citation Analysis]
7 Zhao F, Ma S, Zhou Y, Wei B, Hao Z, Cui X, Xing L, Liu G, Jin L, Ma T, Shi L. miRNA-223 Suppresses Mouse Gallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway. Int J Biol Sci 2021;17:4459-73. [PMID: 34803510 DOI: 10.7150/ijbs.65485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhuang Q, Ye X, Shen S, Cheng J, Shi Y, Wu S, Xia J, Ning M, Dong Z, Wan X. Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota. Front Pharmacol 2021;12:701003. [PMID: 34276384 DOI: 10.3389/fphar.2021.701003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Gijbels E, Pieters A, De Muynck K, Vinken M, Devisscher L. Rodent models of cholestatic liver disease: A practical guide for translational research. Liver Int 2021;41:656-82. [PMID: 33486884 DOI: 10.1111/liv.14800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Qian C, Qiu W, Zhang J, Shen Z, Liu H, Zhang Y. The long non-coding RNA MEG3 plays critical roles in the pathogenesis of cholesterol gallstone. PeerJ 2021;9:e10803. [PMID: 33665015 DOI: 10.7717/peerj.10803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Pitchumoni CS, Ravindran N. Gallstones and Benign Gallbladder Disease. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_54] [Reference Citation Analysis]
12 Wang HH, Liu M, Portincasa P, Wang DQ. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease. Adv Exp Med Biol 2020;1276:105-36. [PMID: 32705597 DOI: 10.1007/978-981-15-6082-8_8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Wang HH, de Bari O, Arnatt CK, Liu M, Portincasa P, Wang DQ. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice. Hepatology 2020;72:2077-89. [PMID: 32112420 DOI: 10.1002/hep.31212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13. Genes (Basel) 2020;11:E1438. [PMID: 33260332 DOI: 10.3390/genes11121438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 DeLeon C, Wang DQ, Arnatt CK. G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases. Front Endocrinol (Lausanne) 2020;11:578536. [PMID: 33281743 DOI: 10.3389/fendo.2020.578536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Zhao F, Ma S, Shen W, Li Y, Peng Z, Cui X, Xing L, Li X, Liu G, Jin L, Ma T, Shi L. MiRNA-223 Inhibits MouseGallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway.. [DOI: 10.1101/2020.10.19.344580] [Reference Citation Analysis]
17 Grigor'eva IN, Romanova TI. Gallstone Disease and Microbiome. Microorganisms 2020;8:E835. [PMID: 32498344 DOI: 10.3390/microorganisms8060835] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
18 Feng X, Zhu C, Lee S, Gao J, Zhu P, Yamauchi J, Pan C, Singh S, Qu S, Miller R, Monga SP, Peng Y, Dong HH. Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice. J Biol Chem 2020;295:7003-17. [PMID: 32273342 DOI: 10.1074/jbc.RA119.012272] [Reference Citation Analysis]
19 Shanmugam H, Molina Molina E, Di Palo DM, Faienza MF, Di Ciaula A, Garruti G, Wang DQH, Portincasa P. Physical Activity Modulating Lipid Metabolism in Gallbladder Diseases. J Gastrointestin Liver Dis 2020;29:99-110. [PMID: 32176752 DOI: 10.15403/jgld-544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 DeLeon C, Wang HH, Gunn J, Wilhelm M, Cole A, Arnett S, Wang DQ, Arnatt CK. A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. J Lipid Res 2020;61:767-77. [PMID: 32127396 DOI: 10.1194/jlr.RA119000592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Pitchumoni CS, Ravindran N. Gallstones and Benign Gallbladder Disease. Geriatric Gastroenterology 2020. [DOI: 10.1007/978-3-319-90761-1_54-1] [Reference Citation Analysis]
22 Tan J, Kou J. Advances in Research on the Pathogenesis of Type 2 Diabetes Complicated with Gallstone. IJCM 2019;10:161-173. [DOI: 10.4236/ijcm.2019.103016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances. Liver Res 2018;2:186-99. [PMID: 34367716 DOI: 10.1016/j.livres.2018.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]